000 01502cam  2200301za 4500
0019.834437
003CaOODSP
00520221107150432
007cr |||||||||||
008170329s2000    onc    #o    f000 0 eng d
040 |aCaOODSP|beng
043 |an-cn---
0861 |aRv3-1/4-1-2000E-PDF
24510|aDrugs and biologicals |h[electronic resource].
260 |a[Ottawa] : |bCanada Customs and Revenue Agency, |c2000.
300 |a5 p.
4901 |aGST/HST memoranda series
500 |aIssued also in French under title: Médicaments et substances biologiques.
500 |aCaption title.
500 |a"June 2000."
500 |aChapter 4.1 of the GST/HST memoranda series.
520 |a"This memorandum in Chapter 4, Zero-Rated Supplies, supersedes Memorandum 4.1, Prescription Drugs and Biologicals, issued in January 1995. Due to the number of revisions, the changes have not been side-barred. This memorandum explains the tax status of drugs and biologicals as they relate to the Goods and Services Tax /Harmonized Sales Tax (GST/HST) provisions of the Excise Tax Act (the Act)"--p. 1.
69207|2gccst|aGoods and services tax
69207|2gccst|aHarmonized sales tax
7101 |aCanada. |bCanada Customs and Revenue Agency.
77508|tMédicaments et substances biologiques |w(CaOODSP)9.834440
830#0|aGST/HST memoranda series (Online)|w(CaOODSP)9.832238
85640|qPDF|s172 KB|uhttps://publications.gc.ca/collections/collection_2017/arc-cra/Rv3-1-4-1-2000-eng.pdf